Bharat Biotech Recruits 23k Volunteers for Covid-19 Vaccine Trials

The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the countrys first and only Phase III efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted for any vaccine in India, a press release from the vaccine maker said on Saturday night.

Leave a Reply

Your email address will not be published. Required fields are marked *